Fabrication and in vitro characterization of delafloxacin-laden electrosprayed hydroxypropyl cellulose nanoparticulated solid dispersions for enhanced aqueous solubility and release rate of the drug

References

• Bassetti, M.; Pecori, D.; Cojutti, P.; Righi, E.; Pea, F. Clinical and Pharmacokinetic Drug Evaluation of Delafloxacin for the Treatment of Acute Bacterial Skin and Skin Structure Infections. Expert Opin. Drug Metab. Toxicol. 2017, 13, 1193–1200. DOI: 10.1080/17425255.2017.1386654.
   PubMed Web of Science ®Google Scholar
• Lee, A.; Lamb, Y. N.; Shirley, M. Delafloxacin: A Review in Community-Acquired Pneumonia. Drugs 2022, 82, 913–923. DOI: 10.1007/s40265-022-01725-z.
   PubMed Web of Science ®Google Scholar
• Anwer, M. K.; Mohammad, M.; Khalil, N. Y.; Imam, F.; Ansari, M. J.; Aldawsari, M. F.; Shakeel, F.; Iqbal, M. Solubility, Thermodynamics and Molecular Interaction Studies of Delafloxacin in Environmental Friendly Ionic Liquids. J. Mol. Liq. 2020, 305, 112854. DOI: 10.1016/j.molliq.2020.112854.
   Web of Science ®Google Scholar
• Anwer, M. K.; Iqbal, M.; Aldawsari, M. F.; Alalaiwe, A.; Ahmed, M. M.; Muharram, M. M.; Ezzeldin, E.; Mahmoud, M. A.; Imam, F.; Ali, R. Improved Antimicrobial Activity and Oral Bioavailability of Delafloxacin by Self-Nanoemulsifying Drug Delivery System (SNEDDS). J. Drug Deliv. Sci. Technol. 2021, 64, 102572. DOI: 10.1016/j.jddst.2021.102572.
   Web of Science ®Google Scholar
• Abu Lila, A. S.; Huwaimel, B.; Alobaida, A.; Hussain, T.; Rafi, Z.; Mehmood, K.; Abdallah, M. H.; Hagbani, T. A.; Rizvi, S. M. D.; Moin, A.; Ahmed, A. F. Delafloxacin-Capped Gold Nanoparticles (DFX-AuNPs): an Effective Antibacterial Nano-Formulation of Fluoroquinolone Antibiotic. Materials (Basel) 2022, 15, 5709. DOI: 10.3390/ma15165709.
   PubMed Web of Science ®Google Scholar
• Yousaf, A. M.; Mustapha, O.; Kim, D. W.; Kim, D. S.; Kim, K. S.; Jin, S. G.; Yong, C. S.; Youn, Y. S.; Oh, Y.-K.; Kim, J. O.; Choi, H.-G. Novel Electrosprayed Nanospherules for Enhanced Aqueous Solubility and Oral Bioavailability of Poorly Water-Soluble Fenofibrate. Int. J. Nanomed. 2016, 11, 213–221. DOI: 10.2147/IJN.S97496.
   PubMed Web of Science ®Google Scholar
• El-Badry, M.; Fathy, M. Enhancement of the Dissolution and Permeation Rates of Meloxicam by Formation of Its Freeze-Dried Solid Dispersions in Polyvinylpyrrolidone K-30. Drug Dev. Ind. Pharm. 2006, 32, 141–150. DOI: 10.1080/03639040500465983.
   PubMed Web of Science ®Google Scholar
• Frank, K. J.; Rosenblatt, K. M.; Westedt, U.; Hölig, P.; Rosenberg, J.; Mägerlein, M.; Fricker, G.; Brandl, M. Amorphous Solid Dispersion Enhances Permeation of Poorly Soluble ABT-102: True Supersaturation vs. Apparent Solubility Enhancement. Int. J. Pharm. 2012, 437, 288–293. DOI: 10.1016/j.ijpharm.2012.08.014.
   PubMed Web of Science ®Google Scholar
• Joe, J. H.; Lee, W. M.; Park, Y.-J.; Joe, K. H.; Oh, D. H.; Seo, Y. G.; Woo, J. S.; Yong, C. S.; Choi, H.-G. Effect of the Solid-Dispersion Method on the Solubility and Crystalline Property of Tacrolimus. Int. J. Pharm. 2010, 395, 161–166. DOI: 10.1016/j.ijpharm.2010.05.023.
   PubMed Web of Science ®Google Scholar
• Sun, R.; Shen, C.; Shafique, S.; Mustapha, O.; Hussain, T.; Khan, I. U.; Mehmood, Y.; Anwer, K.; Shahzad, Y.; Yousaf, A. M. Electrosprayed Polymeric Nanospheres for Enhanced Solubility, Dissolution Rate, Oral Bioavailability and Antihyperlipidemic Activity of Bezafibrate. Int. J. Nanomed. 2020, 15, 705–715. DOI: 10.2147/IJN.S235146.
   PubMed Web of Science ®Google Scholar
• Yousaf, A. M.; Ramzan, M.; Shahzad, Y.; Mahmood, T.; Jamshaid, M. Fabrication and in Vitro Characterization of Fenofibric Acid-Loaded Hyaluronic Acid–Polyethylene Glycol Polymeric Composites with Enhanced Drug Solubility and Dissolution Rate. Int. J. Polym. Mater. Polym. Biomater. 2019, 68, 510–515. DOI: 10.1080/00914037.2018.1466137.
   Web of Science ®Google Scholar
• Konno, H.; Handa, T.; Alonzo, D. E.; Taylor, L. S. Effect of Polymer Type on the Dissolution Profile of Amorphous Solid Dispersions Containing Felodipine. Eur. J. Pharm. Biopharm. 2008, 70, 493–499. DOI: 10.1016/j.ejpb.2008.05.023.
   PubMed Web of Science ®Google Scholar
• Gupta, P.; Kakumanu, V. K.; Bansal, A. K. Stability and Solubility of Celecoxib-PVP Amorphous Dispersions: A Molecular Perspective. Pharm. Res. 2004, 21, 1762–1769. DOI: 10.1023/b:pham.0000045226.42859.b8.
   PubMed Web of Science ®Google Scholar
• Tanno, F.; Nishiyama, Y.; Kokubo, H.; Obara, S. Evaluation of Hypromellose Acetate Succinate (HPMCAS) as a Carrier in Solid Dispersions. Drug Dev. Ind. Pharm. 2004, 30, 9–17. DOI: 10.1081/ddc-120027506.
   PubMed Web of Science ®Google Scholar
• Briseid, G.; Briseid, K.; Kirkevold, K. Increased Intestinal Absorption in the Rat Caused by Sodium Lauryl Sulphate, and Its Possible Relation to the cAMP System. Naunyn Schmiedebergs Arch. Pharmacol. 1976, 292, 137–144. DOI: 10.1007/BF00498584.
   PubMed Web of Science ®Google Scholar
• Miller, J. M.; Beig, A.; Krieg, B. J.; Carr, R. A.; Borchardt, T. B.; Amidon, G. E.; Amidon, G. L.; Dahan, A. The Solubility–Permeability Interplay: mechanistic Modeling and Predictive Application of the Impact of Micellar Solubilization on Intestinal Permeation. Mol. Pharm. 2011, 8, 1848–1856. DOI: 10.1021/mp200181v.
   PubMed Web of Science ®Google Scholar
• Lee, S. N.; Poudel, B. K.; Tran, T. H.; Marasini, N.; Pradhan, R.; Lee, Y. I.; Lee, D. W.; Woo, J. S.; Choi, H.-G.; Yong, C. S.; Kim, J. O. A Novel Surface-Attached Carvedilol Solid Dispersion with Enhanced Solubility and Dissolution. Arch. Pharm. Res. 2013, 36, 79–85. DOI: 10.1007/s12272-013-0008-7.
   PubMed Web of Science ®Google Scholar
• Ha, E.-S.; Kim, J.-S.; Baek, I-h.; Hwang, S.-J.; Kim, M.-S. Enhancement of Dissolution and Bioavailability of Ezetimibe by Amorphous Solid Dispersion Nanoparticles Fabricated Using Supercritical Antisolvent Process. J. Pharm. Investig. 2015, 45, 641–649. DOI: 10.1007/s40005-015-0218-8.
   Google Scholar
• Yousaf, A. M.; Kim, D. W.; Kim, D. S.; Kim, J. O.; Youn, Y. S.; Cho, K. H.; Yong, C. S.; Choi, H.-G. Influence of Polyvinylpyrrolidone Quantity on the Solubility, Crystallinity and Oral Bioavailability of Fenofibrate in Solvent-Evaporated Microspheres. J. Microencapsul. 2016, 33, 365–371. DOI: 10.1080/02652048.2016.1194906.
   PubMed Web of Science ®Google Scholar
• Yousaf, A. M.; Kim, D. W.; Oh, Y.-K.; Yong, C. S.; Kim, J. O.; Choi, H.-G. Enhanced Oral Bioavailability of Fenofibrate Using Polymeric Nanoparticulated Systems: Physicochemical Characterization and In Vivo Investigation. Int. J. Nanomed. 2015, 10, 1819–1830. DOI: 10.2147/IJN.S78895.
   PubMed Web of Science ®Google Scholar
• Sheskey, R. C. R. P. J.; Quinn, M. E. Handbook of Pharmaceutical Excipients, 7th ed., Pharmaceutical Press, London, 2012. DOI: 10.3109/10837450.2012.751408.
   Google Scholar
• Nilsson, T. Y.; Trojer, M. A. A Solution Blown Superporous Nonwoven Hydrogel Based on Hydroxypropyl Cellulose. Soft Matter 2020, 16, 6850–6861. DOI: 10.1039/D0SM00724B.
   PubMed Web of Science ®Google Scholar
• Da Costa, M. A.; Seiceira, R. C.; Rodrigues, C. R.; Hoffmeister, C. R. D.; Cabral, L. M.; Rocha, H. V. A. Efavirenz Dissolution Enhancement I: Co-Micronization. Pharmaceutics 2012, 5, 1–22. DOI: 10.3390/pharmaceutics5010001.
   PubMedGoogle Scholar
• Reis, C. P.; Neufeld, R. J.; Ribeiro, A. J.; Veiga, F. Nanoencapsulation I. Methods for Preparation of Drug-Loaded Polymeric Nanoparticles. Nanomedicine 2006, 2, 8–21. DOI: 10.1016/j.nano.2005.12.003.
   PubMed Web of Science ®Google Scholar
• Soppimath, K. S.; Aminabhavi, T. M.; Kulkarni, A. R.; Rudzinski, W. E. Biodegradable Polymeric Nanoparticles as Drug Delivery Devices. J. Control. Release 2001, 70, 1–20. DOI: 10.1016/s0168-3659(00)00339-4.
   PubMed Web of Science ®Google Scholar